Request PDF on ResearchGate | On Mar 16, , Gemma Ramirez and others published Tratamiento del paciente con trombocitemia esencial. La trombocitemia esencial y embarazo es una asociación infrecuente. Nuestra paciente estaba en estudio por trombocitosis cuando quedó embarazada. 6 Mar Tratamiento del paciente con trombocitemia esencial. Management of patients with essential thrombocythemia. Gemma Ramireza, Ricarda.
|Published (Last):||18 December 2007|
|PDF File Size:||7.29 Mb|
|ePub File Size:||4.45 Mb|
|Price:||Free* [*Free Regsitration Required]|
TROMBOCITEMIA ESENCIAL on Vimeo
Other search option s Alphabetical list. Risk factors associated with arteriosclerotic disease trmobocitemia, diabetes, smoking etc must be actively managed.
The material trombocitemia esencial in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment. Check out this article to learn more or contact your system administrator. Conventional cytoreductive therapies are contra-indicated trombocitemia esencial pregnancy.
Summary and related texts. Send this link to let others join your presentation: Check this box if you wish to receive a copy of your trombocitemia esencial. See more popular or the latest prezis. The detailed pathogenic mechanism is unknown. Do you really want to delete this prezi? Hemostasia y Trombosis, Median age at diagnosis is years, but the disease may trombocitemia esencial at any age, with another peak in incidence in younger women.
Less frequently ET is associated with an increased risk of hemorrhage. Cancel Reply 0 characters used from the allowed. Clinical description The tromboxitemia picture is trombocitemia esencial by a predisposition to vascular occlusive events and hemorrhages. The female to male ratio is esenial 2: Please log in to add your comment. Transformation to myelofibrosis see this term or acute leukemia is possible in a small proportion of patients on trombocitemia esencial long term.
Add a personal note: Specialised Social Services Eurordis directory. ET Essential thrombocytosis Prevalence: Present to your audience Start remote presentation. Creating downloadable prezi, be patient.
Health care resources for this disease Expert centres Diagnostic tests Patient organisations 47 Orphan drug s Only comments seeking to improve the quality and accuracy of information on the Orphanet trombocittemia are accepted. Send link to edit together this prezi using Prezi Meeting learn more: Conventional and pegylated recombinant interferon alpha IFN are effective in controlling platelet trombocitemia esencial, although trombocitemia esencial is trombocitemia esencial evidence of efficacy in preventing thrombosis and could be preferred to conventional ewencial therapies in younger patients.
Present to your audience. For all other comments, please send your remarks via contact us. Differential diagnoses include the other myeloproliferative neoplasms polycythemia vera, primary myelofibrosis, chronic myeloid leukemia; see these terms trombocitemia esencial, myeloid malignancies myelodysplastic syndromecauses of secondary thrombocytosis inflammation, cancer, iron deficiency, asplenia and primary familial thrombocytosis see this term.
Only rtombocitemia written in English can be processed.
Overall survival is similar to that of trombocitemia esencial healthy population grombocitemia by age and sex during the first decade after diagnosis and may differ thereafter due to disease complications such as thrombosis, transformation to myelofibrosis, acute leukemia or trombocitemia esencial.
Differential diagnosis Differential diagnoses include the other myeloproliferative neoplasms polycythemia esencil, primary myelofibrosis, chronic myeloid leukemia; see these termsmyeloid malignancies myelodysplastic syndromecauses of secondary thrombocytosis inflammation, cancer, iron deficiency, asplenia and primary familial thrombocytosis trombocitemia esencial this term.
Comments 0 Please log in to add your comment. Additional information Further information on this disease Classification s 2 Gene s 6 Clinical signs and symptoms Publications in PubMed Other website s 8.
Detailed information Article for general trombocitemia esencial Deutschpdf. Send the link below via email or IM. Constrain to simple back and forward steps. A firewall is blocking access to Prezi content.
Houston, we have a problem! Trombocitemia esencial you, nor the coeditors you shared it with will be able to recover it again.
TROMBOCITEMIA ESENCIAL by Daniela Giraldo O on Prezi
Although ET is usually an acquired non hereditary disease, a familial form, trkmbocitemia familial thrombocytosis see this term has also been observed. Reset trombocitemia esencial links Resets both viewing and editing links coeditors shown below are not affected. Delete comment or cancel. Main risks for patients include thromboses arterial and venouswhich can induce severe neurological, cardiac or peripheral artery manifestations.
Copy code to clipboard.
Invited audience members will follow you as you navigate and present People invited to a presentation do not need a Prezi account This link expires 10 minutes after you close the presentation A maximum of 30 users can follow your presentation Learn more tormbocitemia this feature in our knowledge base article. Some patients trombocitemia esencial ET are asymptomatic, while others may experience microcirculatory disturbances or vasomotor events: Send the link below via email or IM Copy.
Anagrelide is approved in European Union as platelet lowering agent trombocitemia esencial patients resistant or intolerant to hydroxycarbamide. Prognosis Overall survival is similar to that of a healthy population matched by age and sex during the first decade after diagnosis and may differ thereafter due to disease complications such as thrombosis, transformation to trombocitemia esencial, acute leukemia or myelodysplasia.
When trombocitemia esencial managed and carefully followed, life expectancy of ET patients can be similar to that of general population. Hydroxycarbamide and aspirin are effective in high risk patients. Revision,presentacion de estudios de laboratorio. The clinical picture is trombocitemia esencial by esenfial predisposition to vascular occlusive events and hemorrhages.